Novarum Center for Eating Disorders & Obesity, Amsterdam, The Netherlands.
Research Department, Arkin Mental Health Institute, Amsterdam, The Netherlands.
Int J Eat Disord. 2020 Mar;53(3):461-471. doi: 10.1002/eat.23229. Epub 2020 Jan 30.
Even though evidence-based interventions can enhance clinical outcomes and cost effectiveness, in the field of eating disorders, implementation of empirically supported treatments (ESTs) in routine inpatient and outpatient settings is slow.
This study examined differential (cost-) effectiveness, after implementing evidence-based cognitive behavioral therapy-enhanced (CBT-E) throughout a Dutch treatment center.
Two consecutive cohorts of adult patients, BMI between 17.5 and 40, were compared, with one cohort (N = 239) receiving treatment-as-usual (TAU) between 2012 and 2014 and the other (N = 320) receiving CBT-E between 2015 and 2017.
Eating disorder pathology, measured with self-reports, decreased significantly in both cohorts; overall, no differences in clinical outcomes between both cohorts were found. Treatment costs and treatment duration were considerably lower in 2015-2017. When limiting the cost analysis to direct costs, there is a 71% likelihood that CBT-E is more cost-effective and a 29% likelihood that CBT-E leads to fewer remissions at lower costs, based on the distribution of the cost-effectiveness plane. The likelihood that TAU leads to lower costs is 0%.
Findings show that implementing an EST throughout inpatient and outpatient settings leads to lower costs with similar treatment effect and has the advantage of shorter treatment duration and a shorter inpatient stay.
尽管循证干预措施可以提高临床结果和成本效益,但在饮食障碍领域,在常规住院和门诊环境中实施经验支持的治疗方法(EST)进展缓慢。
本研究在荷兰治疗中心实施基于循证的认知行为疗法增强(CBT-E)后,检查了其差异(成本)效益。
比较了两个连续的成年患者队列,BMI 在 17.5 到 40 之间,一个队列(N=239)在 2012 年至 2014 年接受常规治疗(TAU),另一个队列(N=320)在 2015 年至 2017 年接受 CBT-E。
两个队列的饮食障碍病理(通过自我报告衡量)均显著下降;总体而言,两个队列的临床结果没有差异。2015-2017 年的治疗成本和治疗时间明显降低。当将成本分析限于直接成本时,根据成本效益平面的分布,CBT-E 更有可能具有成本效益,且花费更少的成本达到更多缓解的可能性为 71%,而 CBT-E 导致更少缓解但成本更低的可能性为 29%。TAU 导致成本降低的可能性为 0%。
研究结果表明,在住院和门诊环境中实施 EST 可降低成本,同时具有相似的治疗效果,并具有治疗时间更短和住院时间更短的优势。